Source link : https://www.newshealth.biz/health-news/chemo-free-triplet-yields-68-response-rate-in-richter-transformation/
A three-drug regimen involving a PD-L1 inhibitor and two targeted agents was active and safe for treating the diffuse large B-cell lymphoma (DLBCL) variant of Richter transformation, the phase II MOLTO study found. Among 28 previously untreated patients, the overall response rate reached 67.9% (95% CI 47.6-84.1) following six cycles of atezolizumab (Tecentriq) plus venetoclax […]
Author : News Health
Publish date : 2024-09-16 14:33:16
Copyright for syndicated content belongs to the linked Source.
Categories